Pancreatic Cancer Research

ResearcherUniversity of Newcastle AustraliaNo recent work listed

Adam McCluskey

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7125-863X; OpenAlex author ID A5026633618. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers

Papers 5

  1. Expansion of a Synthesized Library of N-Benzyl Sulfonamides Derived from an Indole Core to Target Pancreatic Cancer. Co-author DOI 10.1002/cmdc.202300265↗
  2. Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer. Last author DOI 10.1039/d2md00289b↗
  3. 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety. Last author DOI 10.1016/j.bmcl.2022.128591↗
  4. Small molecule inhibitors in pancreatic cancer. Last author DOI 10.1039/c9md00447e↗
  5. The Bispidinone Derivative 3,7-Bis-[2-(S)-amino-3-(1H-indol-3-yl)-propionyl]-1,5-diphenyl-3,7-diazabicyclo[3.3.1]nonan-9-one Dihydrochloride Induces an Apoptos… Co-author DOI 10.3390/molecules24030524↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher James Scarlett · 4 shared papers, 2019–2023 · strength 0.60
  2. Ju‐Feng Sun · 3 shared papers, 2020–2023 · strength 0.51
  3. Chloé Goldsmith · 1 shared paper, 2023 · strength 0.18
  4. Hong Ngoc Thuy Pham · 1 shared paper, 2023 · strength 0.18
  5. Megan D. Hopkins · 1 shared paper, 2023 · strength 0.16
  6. Zachary C. Brandeburg · 1 shared paper, 2023 · strength 0.16
  7. Angus A. Lamar · 1 shared paper, 2023 · strength 0.16
  8. Melanie J. Predebon · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.